June 2024 FDA Recall Dianeal Low Calcium With Dextrose by Baxter Healthcare Corporation
D-0587-2024 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Baxter Healthcare Corporation on June 17, 2024 for the product Dianeal Low Calcium With Dextrose. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0587-2024

Reason for Recall
Lack of Assurance of Sterility: Potential presence of leaks originating from the Connector Assembly component.
Initiated
06-17-2024
Reported
07-17-2024
Quantity
6,874 bags

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Baxter Healthcare Corporation
US Nationwide, Canada
Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose, For Intraperitoneal Administration Only, 6000 mL per bag, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA. NDC: 0941-0457-01

Batch or Lot Expiration Information

Lot# Lot R24B25FA; Exp. 2/28/2026

Affected Packages Involved in this Recall